5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision 2030’, the country’s leading…
Searching for "Novartis" found 144
The Collaborative Spirit of Cell & Gene
One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they are not just technologically…
Henry Suárez – President, ARAPF, Dominican Republic
The Association of Representatives, Agents and Pharmaceutical Producers (ARAPF), represents 65 companies in the Dominican Republic, including big…
Reconsidering Cell & Gene Therapy Manufacturing
Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating an inflection point in the ability…
Biogen’s Swiss Head on Benefits of Diverse Experience…
A trained physician with several years of practice under her belt, Katharina Gasser then moved into clinical research as an investigator before…
Susan M. Gasser – Director Emeritus & Group Leader,…
Professor Susan M. Gasser, now director and group leader emeritus of the Friedrich Miescher Institute for Biomedical Research (FMI), shares the…
Top 10 Global Rare Disease Companies
The Top 10 rare disease companies globally, ranked by worldwide orphan drug sales for 2018. Celgene takes top spot, followed by Roche and Novartis.…
China’s National Reimbursement Drug List (NRDL) 2020: What…
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact that a de facto annual review has…
China: New Year, New Round of Drug Price Cuts
Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug expenditures in 2018, the world’s…
Funding the Cell & Gene Therapy Boom
The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the history of the pharmaceuticals…
Vaccines: Market Model Innovation
While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the pharmaceutical industry, vaccines are also…
RWE: Unlocking the Full Potential of Cell & Gene
Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems: carrying the potential to offer…
